Orchestra BioMed (NASDAQ: OBIO) reported Q3 EPS of ($0.38), $0.04 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $420 thousand.

For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.